Click on image to view larger version.

Figure 4 ARMYDA-ACS: Odds Ratios for 30-Day MACE

Results of multivariable analysis showing 88% major adverse cardiac event (MACE) risk reduction at 30 days with atorvastatin (odds ratio 0.12, 95% confidence interval 0.05 to 0.50; p = 0.004). ACE = angiotensin-converting enzyme; LVEF = left ventricular ejection fraction; NSTEMI = non–ST-segment elevation myocardial infarction.